News Takara Bio Inc.

Equities

4974

JP3460200003

Market Closed - Japan Exchange Other stock markets 11:30:00 25/06/2024 am IST			5-day change	1st Jan Change
1,053 ^JPY	+0.67%		+3.64%	-15.89%

18/03	Takara Bio Inc.(TSE:4974) dropped from FTSE All-World Index	CI
15/02	Takara Bio's Attributable Income Falls 98.9% in Fiscal Nine Months	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Takara Bio : Notice of the 22nd Annual General Meeting of Shareholders	29/05	PU
Takara Bio Inc. Proposes Dividend for the Fiscal Year Ending March 31, 2024, Effective June 24, 2024	10/05	CI
Takara Bio transforms single-cell landscape with new large-scale NGS profiling system for oncology biomarker discovery	03/04	AQ
Final dividend	28/03	FA
Takara Bio Inc.(TSE:4974) dropped from FTSE All-World Index	18/03	CI
Acute Lymphocytic Leukemia Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2024	22/02	AQ
Takara Bio's Attributable Income Falls 98.9% in Fiscal Nine Months	15/02	MT
Takara Bio's first-to-market large-scale single-cell NGS profiling technologies poised to revolutionize biomarker discovery	06/02	AQ
Acute Lymphocytic Leukemia Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2023 (Updated)	22/12	AQ
Takara Bio USA wins EU opposition hearing, revoking Jumpcode Genomics NGS library enrichment patent	12/12	AQ
Takara Bio Inc. Revises Consolidated Earnings Guidance for the Year Ending March 31, 2024	09/11	CI
Takara Bio : Annual Report 2023	13/23/13	PU
Jefferies Adjusts Takara Bio’s Price Target to 1,900 Yen From 2,000 Yen, Keeps at Hold	25/23/25	MT
Takara Bio : Financial Results Presentation (May 16, 2023)	29/23/29	PU
Takara Bio : Notice of the 21th Annual General Meeting of Shareholders	23/23/23	PU
Takara Bio : Consolidated Financial Statements for FY Ended March 31 2023	11/23/11	PU
Takara Bio Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	11/23/11	CI
Ex-dividend day for final dividend	30/23/30	FA
Takara Bio Inc. Provides Dividend Guidance for the Fiscal Year Ending Mar. 31, 2023	09/23/09	CI
Takara Bio Inc. Revised Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023	09/23/09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Takara Bio Inc.

Equities

4974

JP3460200003

Summary

Filters